JAMA Cardiology Review Time
JAMA Cardiology's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.
What to do next
Already submitted to JAMA Cardiology? Use this page to interpret the status and choose the next step.
The useful next step is understanding what the status usually means at JAMA Cardiology, how long the wait normally runs, and when a follow-up is actually reasonable.
JAMA Cardiology review timeline: what the data shows
Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.
What shapes the timeline
- Desk decisions are fast. Scope problems surface within days.
- Reviewer availability is the main variable after triage. Specialized topics take longer to assign.
- Revision rounds reset the clock. Major revision typically adds 6-12 weeks per round.
What to do while waiting
- Track status in the submission portal — status changes signal active review.
- Wait at least the journal's stated median before sending a status inquiry.
- Prepare revision materials in parallel if you expect a revise-and-resubmit decision.
Quick answer: JAMA Cardiology review time runs two clear tracks (per JAMA Network publisher portal at jamanetwork.com). Desk decisions land in 8 days median for clearly out-of-scope work (without external peer review), and the full-review path takes 51 days median to first decision with peer review per JAMA Network author guidelines. That means the journal is genuinely fast at the front end, but the useful interpretation is not merely speed. It is that JAMA Cardiology forms a view quickly on whether the manuscript matters broadly enough to clinical cardiology.
Last reviewed: 2026-05-17.
Community-reported metrics. SciRev community data on JAMA Cardiology currently shows N=0 community-submitted reviews, with only an immediate-rejection signal of about 10 days reported by the community (per SciRev). The thin community sample reflects that most JAMA Cardiology authors rely on the JAMA Network publisher portal's reported medians (8 days / 51 days) rather than community reporting.
JAMA Cardiology metrics at a glance
Metric | Current value | What it means for authors |
|---|---|---|
Median first decision without peer review | 8 days | The desk screen is fast and unforgiving |
Median first decision with peer review | 51 days | Reviewed manuscripts still move on a moderate clinical-journal clock |
Acceptance rate | 9% | The editorial gate is narrow |
Impact Factor (JCR 2024) | 14.1 | JAMA Cardiology remains a top clinical-cardiology venue |
SJR (SCImago 2024) | 5.936 | Prestige remains high among cardiology journals |
Annual article views and downloads | 5.6M+ | Reach is substantial for accepted papers |
Main fit test | Broad clinical cardiology consequence | Narrow subspecialty stories are fragile here |
Publisher | JAMA Network | The journal rewards concise, practice-facing framing |
These numbers explain why the journal can feel both efficient and harsh. It really does move quickly, but it moves quickly because the audience test is strict.
What the official sources do and do not tell you
JAMA Cardiology's official about page is unusually useful. It tells authors directly that the median is 8 days without peer review and 51 days with peer review (based on SciRev reports and publisher guidelines).
That split matters because it reveals the journal's operating logic:
- the front door is a triage system, not just an administrative step
- reviewed papers get a more normal cardiology-journal timeline
- the journal knows very early whether the manuscript is broad enough for its readership
What the official page does not tell you is how often timing pain is really positioning pain. A good cardiology paper can still be a bad JAMA Cardiology paper if the consequence is too narrow.
A practical timeline authors can actually plan around
Stage | Practical expectation | What is happening |
|---|---|---|
Initial editorial scan | 1 to 3 days | Editors test whether the question matters to broad cardiology practice |
Desk decision | Around the official 8-day median | Narrow, weakly practical, or methodologically fragile papers stop early |
Reviewer recruitment | About 1 to 2 weeks | Reviewers are matched around design and clinical consequence |
First review round | Around the official 51-day median with review | Reviewers test rigor, interpretability, and practice consequence |
Revision cycle | About 4 to 8 weeks | Most viable papers still need tighter clinical framing or analysis |
Publication path | Fast once accepted (2 to 3 weeks) | JAMA Network is optimized for broad dissemination |
Source: JAMA Network publisher journal metrics + author guidelines (jamanetwork.com portal); ranges reflect typical bands rather than worst-case outliers.
That is the cleanest planning model. The journal is fast at deciding whether your manuscript belongs, then more normal once it commits reviewer time.
Why JAMA Cardiology often feels fast at the desk
JAMA Cardiology has a very clear editorial identity. Editors can reject quickly when a paper is:
- too subspecialty-specific for a broad clinical-cardiology readership
- technically sound but weak on practice consequence
- methodologically interesting without a visible patient-care implication
- more naturally suited to JACC, Circulation, or a narrower specialty venue
- framed around prestige rather than a concrete clinical question
That is why the 8-day desk number is credible. The journal is not searching slowly for fit. It is testing practice relevance immediately.
What usually slows JAMA Cardiology down
The slower papers are usually not obvious rejects. They are the papers close enough to argue about.
The common causes are:
- reviewer concern about whether the result really changes management
- questions about generalizability, endpoint choice, or analytic discipline
- debate over whether the manuscript is broad cardiology or still subspecialty-first
- revisions that improve wording but still leave the clinical consequence underpowered
- tension between statistical rigor and the strength of the headline claim
When JAMA Cardiology feels slow, it is usually because the journal thinks the paper might matter, but only if the evidence and framing become harder to dispute.
JAMA Cardiology citation metric trend and what it means for review time
For year-over-year impact factor data, see the jama cardiology citation metric page.
JAMA Cardiology is down from 14.7 in 2023 to 14.1 in 2024, which is best read as normalization after the COVID-era citation spike rather than a sign of weakening editorial leverage. The journal still has enough status to reject quickly and still demand broad clinical relevance.
For review time, that matters because the journal does not need to widen its audience to hold position. It can keep the front-end screen sharp.
How JAMA Cardiology compares with nearby journals on timing
Journal | Timing signal | Editorial posture |
|---|---|---|
JAMA Cardiology | Fast desk split, moderate reviewed path | Broad clinical cardiology with JAMA discipline |
JACC | Fast flagship cardiology triage | Broad clinical-cardiology audience with family routing |
Circulation | Similar high-pressure clinical screen | AHA flagship clinical cardiology |
European Heart Journal | Elite global-cardiology lane | Broad and prestigious but with a different editorial culture |
JACC specialty journals | Better fit for narrower clinical lanes | Imaging, HF, EP, interventions, and more |
This matters because many JAMA Cardiology timing frustrations are actually venue frustrations. A paper can be excellent and still not be broad enough for this room.
What review-time data hides
Even with this good official split, a few things stay hidden:
- the 8-day number is mostly a triage number, not a peer-review number
- 51 days with review still says nothing about whether the eventual revision will be easy
- timing does not tell you whether the paper is clinically broad enough
- a fast no can still reflect a correct venue judgment, not weak science
So the numbers are useful, but they only make sense if paired with the journal's audience standard.
Readiness check
While you wait on JAMA Cardiology, scan your next manuscript.
The scan takes about 1-2 minutes. Use the result to decide whether to revise before the decision comes back.
In our pre-submission review work with JAMA Cardiology manuscripts
In our pre-submission review work, the biggest timing mistake is treating JAMA Cardiology like a prestige upgrade for a narrow cardiology paper. The journal usually detects that fast.
The manuscripts that move best tend to have:
- a clinical question legible to general cardiology readers
- a main figure or table that makes the practical consequence visible quickly
- analytic discipline strong enough to survive skeptical review
- a cover letter that argues readership fit rather than brand aspiration
Those traits let the fast desk screen work for the paper instead of against it.
What do pre-submission reviews reveal about JAMA Cardiology (American Medical Association) review delays?
In our pre-submission review work on JAMA Cardiology-targeted manuscripts, three patterns most consistently predict slow review at JAMA Cardiology (American Medical Association). Of manuscripts we screened in 2025 targeting JAMA Cardiology and peer venues, the patterns below are the same ones our reviewers flag in real time. The named editorial-culture quirk: JAMA Cardiology editors apply practice-relevance threshold; preclinical-only papers without clinical-application pathway get rejected within 7 days.
Scope-fit ambiguity in the abstract. JAMA Cardiology editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (cardiovascular research with practice-relevant implications for US-based clinical cardiologists). The named failure pattern: preclinical-only cardiology papers without clinical-application pathway get desk-rejected within 7 days. Check whether your abstract reads to JAMA Cardiology's scope →
Methods package incomplete for the journal's reviewer pool. JAMA Cardiology reviewers expect specific methodological detail. Trials with pre-specified primary endpoint not matching headline finding extend revision. Check if your methods package is reviewer-complete →
Reference-list and clean-citation failure mode. Editorial team at JAMA Cardiology (American Medical Association) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch →
Editorial detail (for desk-screen calibration). Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: https://jamanetwork.com/journals/jama/pages/instructions-for-authors. Manuscript constraints: 350-word abstract limit and 3,000-word main-text cap (JAMA Cardiology enforces strict word counts). We reviewed each of these constraints against current journal author guidelines (accessed 2026-05-08); evidence basis for the patterns above includes both publicly documented author-guidelines and our internal anonymized submission corpus.
Manusights submission-corpus signal for JAMA Cardiology (American Medical Association). Of the manuscripts our team screened before submission to JAMA Cardiology and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is JAMA Cardiology editors apply practice-relevance threshold; preclinical-only papers without clinical-application pathway get rejected within 7 days. In our analysis of anonymized JAMA Cardiology-targeted submissions, the documented review timeline shows a bimodal distribution between manuscripts that clear JAMA Cardiology's scope-fit threshold within the first week and those that get extended editorial-board consultation. Top-line triage is handled by the journal's editorial team; verify the current handling editor on the journal's editorial-team page before quoting any name in a cover letter.
Submit If
- The headline finding fits JAMA Cardiology (American Medical Association)'s editorial scope (cardiovascular research with practice-relevant implications for US-based clinical cardiologists) and the abstract names that fit within the first 100 words for JAMA Cardiology's editorial-team triage.
- The methods section is detailed enough for JAMA Cardiology reviewers to evaluate without follow-up; protocol and reproducibility detail are in the main text rather than deferred to supplementary materials.
- The reference list is clean of recently retracted citations.
- A figure or table makes the contribution visible without specialist translation; the cover letter explicitly names the JAMA Cardiology-relevant audience the work is aimed at.
Think Twice If
- Preclinical-only cardiology papers without clinical-application pathway get desk-rejected within 7 days; this is the named JAMA Cardiology desk-screen failure mode our team flags before submission.
- The cover letter spends a paragraph on background before the new finding appears in the abstract; JAMA Cardiology's editorial culture treats this as a scope-fit warning.
- The reference list cites a paper that has since been retracted without acknowledging the retraction notice.
- The protocol or methodology section relies on more than 3 figures of supplementary material that should be in the main text for JAMA Cardiology's reviewer pool.
What should drive the submission decision instead
For JAMA Cardiology, timing matters less than broad clinical consequence. The better question is whether the manuscript already behaves like a JAMA Cardiology paper.
That is why the better next reads are:
- JAMA Cardiology journal profile
- JAMA Cardiology submission guide
- JAMA Cardiology submission process
- JAMA Cardiology cover letter guide
A JAMA Cardiology practice-relevance check is usually more useful than trying to optimize around the 8-day desk number.
Practical verdict
JAMA Cardiology review time is fast because the journal knows what it wants. The official split between desk decisions and reviewed decisions is real and helpful. If the paper belongs in broad clinical cardiology, the process can move efficiently. If not, the speed mostly delivers an early answer.
The Manusights JAMA Cardiology readiness scan. This guide tells you what JAMA Cardiology (American Medical Association)'s editors look for in the first 1-2 weeks of triage. The review tells you whether YOUR paper passes that check before you submit. We have reviewed manuscripts targeting JAMA Cardiology (American Medical Association) and peer venues; the named patterns below are the same ones the journal's handling editors and outside reviewers flag at the desk-screen and first-review stages. Median 2.5 months to first decision; desk-screen typically completes within 7 days. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.
Frequently asked questions
JAMA Cardiology currently reports a median of 8 days to first decision without external peer review and 51 days with peer review. That is one of the clearest official timing splits among top cardiology journals.
Yes. The journal's official 8-day median without review shows that it filters misfit or insufficiently practice-relevant submissions very quickly.
The biggest causes are debate about whether the paper really matters to broad cardiology practice, methodological concerns that need careful reviewer input, and revisions aimed at tightening the clinical consequence rather than just polishing prose.
Broad clinical relevance matters more than speed. If the manuscript reads as a narrow subspecialty paper or a technically good result without practice consequence, the fast clock mostly works against it.
Sources
- 1. For Authors: JAMA Cardiology, JAMA Network.
- 2. JAMA Cardiology Year in Review, 2025, JAMA Network.
- 3. JAMA Cardiology Year in Review, 2024, JAMA Network.
- 4. JAMA Cardiology Year in Review, 2023, JAMA Network.
- 5. SCImago cardiology journal rankings, SCImago.
Best next step
Use this page to interpret the status and choose the next sensible move.
For JAMA Cardiology, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.
Guidance first. Use the scan for the next manuscript.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- JAMA Cardiology 'Under Review': What Each Status Means
- JAMA Cardiology Submission Process: Steps & Timeline (2026)
- How to Avoid Desk Rejection at JAMA Cardiology
- JAMA Cardiology Impact Factor 2026: 14.1, Q1, Rank 7/230
- Is JAMA Cardiology a Good Journal? The JAMA Network's Cardiovascular Title
- JAMA Cardiology Submission Guide
Supporting reads
Use this page to interpret the status and choose the next sensible move.
Guidance first. Use the scan for the next manuscript.